Literature DB >> 16493500

Developmental haemostasis. Impact for clinical haemostasis laboratories.

Paul Monagle1, Chris Barnes, Vera Ignjatovic, Janine Furmedge, Fiona Newall, Anthony Chan, Lidia De Rosa, Simone Hamilton, Philip Ragg, Stephen Robinson, Alex Auldist, Cathy Crock, Neil Roy, Shelley Rowlands.   

Abstract

Developmental haemostasis is a concept, now universally accepted, introduced by Andrew et al. in the late 1980's. However, coagulation analysers and reagents have changed significantly over the past 15 years. Coagulation testing is known to be sensitive to changes in individual reagents and analysers. We hypothesised that the reference ranges developed by Andrew et al. may not be appropriate for use in a modern coagulation laboratory. Our study was designed to determine whether a current day coagulation testing system (STA Compact analyser and Diagnostica Stago reagent system) was sensitive to age-related changes in coagulation assays. This is the first large scale study since Andrew et al. to determine the age associated numerical changes in coagulation proteins. Our results confirm the concepts of developmental haemostasis elucidated by Andrew et al. However, our results clearly demonstrate that the absolute values of reference ranges for coagulation assays in neonates and children vary with analyser and reagent systems. The results confirm the need for coagulation laboratories to develop age-related reference ranges specific to their own testing systems. Without this, accurate diagnosis and management of neonates and children with suspected bleeding or clotting disorders is not possible. Finally we present age related reference ranges for D-dimers, TFPI, and endogenous thrombin potential, previously not described.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16493500     DOI: 10.1160/TH05-01-0047

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  66 in total

Review 1.  How We Manage Pediatric Deep Venous Thrombosis.

Authors:  Marisol Betensky; Mark A Bittles; Paul Colombani; Neil A Goldenberg
Journal:  Semin Intervent Radiol       Date:  2017-03       Impact factor: 1.513

2.  Clotting screen requests in pediatrics.

Authors:  Jecko Thachil; Gail Ann Whitehead
Journal:  Indian J Pediatr       Date:  2011-12-15       Impact factor: 1.967

3.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

4.  Letter to the Editor regarding "Routine coagulation tests in newborn and infants".

Authors:  Vera Ignjatovic; Fiona Newall; Robyn Summerhayes; Paul Monagle
Journal:  J Thromb Thrombolysis       Date:  2007-09-14       Impact factor: 2.300

5.  Developmental changes in soluble CD40 ligand.

Authors:  Jill M Cholette; Neil Blumberg; Richard P Phipps; Michael P McDermott; Kelly F Gettings; Norma B Lerner
Journal:  J Pediatr       Date:  2007-10-24       Impact factor: 4.406

Review 6.  Renal vascular thrombosis in the newborn.

Authors:  Lourdes Paula R Resontoc; Hui-Kim Yap
Journal:  Pediatr Nephrol       Date:  2015-07-15       Impact factor: 3.714

7.  An evidence-based standardized protocol for anticoagulation following congenital heart surgery.

Authors:  Catherine Deshaies; Nancy Poirier; Paul Khairy
Journal:  Transl Pediatr       Date:  2018-10

Review 8.  Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery.

Authors:  Colleen E Gruenwald; Cedric Manlhiot; Lynn Crawford-Lean; Celeste Foreman; Leonardo R Brandão; Brian W McCrindle; Helen Holtby; Ross Richards; Helen Moriarty; Glen Van Arsdell; Anthony K Chan
Journal:  J Extra Corpor Technol       Date:  2010-03

9.  Assessment and treatment of stroke in children.

Authors:  Lori C Jordan
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

10.  Monitoring unfractionated heparin in pediatric patients with congenital heart disease having cardiac catheterization or cardiac surgery.

Authors:  G G Kim; S El Rouby; J Thompson; A Gupta; J Williams; D R Jobes
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.